Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Rating of “Buy” from Analysts
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received an average recommendation of “Buy” from the eight research firms that are covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covered the stock in the last year is […]
Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received an average recommendation of “Buy” from the eight research firms that are covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covered the stock in the last year is […]
